NSEGeneral Updates2 Jul 2026 · 2 Jul 2026, 03:40 pm
General Updates
Medplus Health Services Limited · MEDPLUS
✦ AI Summary▼ NegativeRegulatory
Medplus Health Services Limited has informed the Exchange about General Updates, specifically a suspension order for a Drug License of a store situated in the state of Bangalore, resulting in a potential revenue loss of Rs 5.13 lacs.
Analysis Scores
Earnings Impact6/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment3/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Medplus Health Services Limited has informed the Exchange about General Updates
Attachments (1)
📄pdf
Download →
MEDPLUS_02072026154003_Intimation.pdf
View document text
MedPlus Health Services Limited
July 02, 2026
The Listing Department The Listing Department
BSE Limited N ational Stock Exchange of India Limited
Phiroze Jeejebhoy Towers, Exchange Plaza, 5th Floor
Dalal Street, Fort, Plot No. C/1, G Block,
Mumbai – 400001 Bandra - Kurla Complex
BSE Scrip Code: 543427 Bandra (East), Mumbai – 400051
NSE Symbol: MEDPLUS
Dear Sir/Madam,
Sub: Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015.
We would like to inform you that Optival Health Solutions Private Limited, a subsidiary of the company, has
received one suspension order for a Drug License of a store situated in the state of Bangalore:
Pursuant to SEBI Listing Regulations read along with SEBI Master Circular No. HO/49/14/14(7)2025-CFD
POD2/I/3762/2026 dated January 30, 2026, the details of the matter are as follows:
Name(s) of the Nature and details of Date of receipt of Details of the Impact on
Authority the action(s) taken, direction or order, violation(s)/ financial
initiated or order(s) including any contravention(s) operation or
passed interim or interim committed or other activities
orders, or any other alleged to be of the listed
communication committed entity,
from the authority quantifiable in
monetary terms
to the extent
possible
Assistant Director, Suspension of Drug Order received on Under Rule 65 of Potential
Drugs Control License for three days 01.07.2026 Drugs and Revenue Loss of
Administration of store situated at Cosmetics Act, Rs 5.13 lacs.
Bangalore Circle-1, Subramanyanagar 1940 and Drugs
Bangalore Rajajinagar, Bangalore and Cosmetics
Rules, 1945
The same will be available on the website of the Company at www.medplusindia.com and also on the websites
of BSE Limited and National Stock Exchange of India Ltd. viz. www.bseindia.com and www.nseindia.com
respectively. Kindly take the same on records.
For MedPlus Health Services Limited
Gangadi Madhukar Reddy
Managing Director and Chief Executive Officer
DIN: 00098097
040-6724 672
Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India
CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com